Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Harold W, de Valk"'
Autor:
Jessica C.G. Bak, Erik H. Serné, Rolf H.H. Groenwold, Harold W. de Valk, Mark H.H. Kramer, Max Nieuwdorp, Carianne L. Verheugt
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-11 (2023)
Abstract Aims The COVID-19 pandemic impacted diabetes care by reducing diabetes outpatient visits and diabetes-related screening due to allocation of healthcare resources. Yet the impact of COVID-19 on diabetes outpatients has not been extensively ev
Externí odkaz:
https://doaj.org/article/0745385d6f2d49b8afaaf56affabd4be
Autor:
Frank J Snoek, Karel G M Moons, Mirjam M Oosterwerff, Thomas van Bemmel, Catherine B Brouwer, Arianne C van Bon, Harold W de Valk, J Hans deVries, Lioe-Ting Dijkhorst-Oei, Peter R van Dijk, Klaas Hoogenberg, Sarah E Siegelaar, Titia M Vriesendorp, Erik H Serné, Geert W J Frederix, Milena Jancev, Heleen Knottnerus, Helga Blauw, Maureen Witkop, Thomas T van Sloten, Frits A W Kemperman, Lars P Klieverik, Elin Seebus
Publikováno v:
BMJ Open, Vol 13, Iss 8 (2023)
Introduction The management of type 1 diabetes (T1DM) has undergone significant advancements with the availability of novel technologies, notably continuous and flash glucose monitoring (CGM and FGM, respectively) and hybrid closed loop (HCL) therapy
Externí odkaz:
https://doaj.org/article/dd5f612a68824e97a555e2b0371f2a8f
Autor:
Lisanne C. A. Smidt, Frank L. J. Visseren, Wendela L. de Ranitz-Greven, Hendrik M. Nathoe, L. Jaap Kappelle, Gert J. de Borst, Harold W. de Valk, Jan Westerink, the UCC-SMART Study Group
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)
Abstract Background Recent treatment guidelines support the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes and cardiovascular disease based on the results of cardiovascular outcome trials (CVOTs). Applicabi
Externí odkaz:
https://doaj.org/article/f3a9a7dde06648ed9979c46353fab63c
Autor:
Jessica C. G. Bak, Dick Mul, Erik H. Serné, Harold W. de Valk, Theo C. J. Sas, Petronella H. Geelhoed-Duijvestijn, Mark H. H. Kramer, Max Nieuwdorp, Carianne L. Verheugt
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Treatment of diabetes mellitus has majorly improved over the past century, however, the disease burden is high and its prevalence still expanding. Further insight in the diabetes population is imperative to improve the quality of
Externí odkaz:
https://doaj.org/article/13adcf85922249a9beb0ee2093fbbe5b
Autor:
Femke Rutters, Bastiaan E de Galan, Harold W de Valk, J Hans deVries, Miranda T Schram, Coen D A Stehouwer, Bruce H R Wolffenbuttel, Lian A van Meijel, Femmie de Vegt, Evertine J Abbink, Melanie M van der Klauw, Sarah Siegelaar, Behiye Özcan, Bianca Silvius, Nicolaas Schaper, Cornelis J Tack
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
ObjectivePeople with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemia can cause impaired awareness of hypoglycemia (IAH), and increase the risk for severe hypoglycemia. The aim of this study was to assess the prevalence
Externí odkaz:
https://doaj.org/article/ec591d3f74984107ae35e56b61b10833
Autor:
Femke Rutters, Cees J Tack, Harold W de Valk, J Hans deVries, Miranda T Schram, Coen D A Stehouwer, Bruce H R Wolffenbuttel, Evertine J Abbink, Behiye Özcan, Petra J M Elders, Marieke J Oskam, Sarah E Siegelaar, Marielle Schroijen, Ingrid Jazet, L‘t Hart, N C Schaper, O M Dekkers, B Ozcan, B Silvius, M M van der Klauw
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
Introduction Sex differences in cardiometabolic risk factors and their management in type 2 diabetes (T2D) have not been fully identified. Therefore, we aimed to examine differences in cardiometabolic risk factor levels, pharmacological treatment and
Externí odkaz:
https://doaj.org/article/6c4b4b228d08440486f2767fbb682875
Autor:
Ruth Timmer, Laurens Bogaardt, Walter J. Brummelhuis, Conny T. van Oostrom, Linda W.M. van Kerkhof, Albert Wong, Harold W. de Valk, Marga C. Ocké, Tessa van der Maaden, Martijn E.T. Dollé
Publikováno v:
Chronobiology International 39 (2022) 10
Chronobiology International, 39(10), 1329-1339
Chronobiology International, 39(10), 1329-1339
The postprandial glycemic response is an important metabolic health factor, which, from laboratory studies, is known to change from low to high over the course of the day, and from which negative health outcomes have been linked to nightly eating. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc418e2e730eb4b1a63421fd1348332
https://doi.org/10.1080/07420528.2022.2105230
https://doi.org/10.1080/07420528.2022.2105230
Autor:
Floris Groenendaal, Arie Franx, Rebecca C Painter, Ben Willem Mol, Bas B Van rijn, Leon de Wit, Doortje Rademaker, Daphne N Voormolen, Bettina M C Akerboom, Rosalie M Kiewiet-Kemper, Maarten R Soeters, Marion A L Verwij-Didden, Fahima Assouiki, Daniela H Schippers, Mechteld A R Vermeulen, Simone M I Kuppens, Mirjam M Oosterwerff, Joost J Zwart, Mattheus J M Diekman, Tatjana E Vogelvang, P Rob J Gallas, Sander Galjaard, Willy Visser, Nicole Horree, Tamira K Klooker, Rosemarie Laan, Rik Heijligenberg, Anjoke J M Huisjes, Thomas van Bemmel, Claudia A van Meir, Annewieke W van den Beld, Wietske Hermes, Solrun Vidarsdottir, Anneke G Veldhuis-Vlug, Remke C Dullemond, Henrique J Jansen, Marieke Sueters, Eelco J P de Koning, Judith O E H van Laar, Pleun Wouters-van Poppel, Marina E Sanson-van Praag, Eline S van den Akker, Catherine B Brouwer, Brenda B Hermsen, Bert Jan Potter van Loon, Olivier W H van der Heijden, Bastiaan E de Galan, Marsha van Leeuwen, Johanna A M Wijbenga, Karin de Boer, Arianne C van Bon, Flip W van der Made, Silvia A Eskes, Mirjam Zandstra, William H van Houtum, Babette A M Braams-Lisman, Catharina R G M Daemen-Gubbels, Maurice G A J Wouters, Richard G IJzerman, Nico A Mensing van Charante, Rolf Zwertbroek, Inge M Evers, Harold W de Valk, J Hans deVries
Publikováno v:
BMJ Open, Vol 9, Iss 8 (2019)
Introduction In women with gestational diabetes mellitus (GDM) requiring pharmacotherapy, insulin was the established first-line treatment. More recently, oral glucose lowering drugs (OGLDs) have gained popularity as a patient-friendly, less expensiv
Externí odkaz:
https://doaj.org/article/fcbb937143a248c0b10a815934bf79df
Autor:
Erik H. Serné, Stéphane Roze, Maria I. Buompensiere, William J. Valentine, Simona de Portu, Harold W. de Valk
Publikováno v:
Advances in therapy, 40(5), 2545-2548. Health Communications Inc.
Serné, E H, Roze, S, Buompensiere, M I, Valentine, W J, de Portu, S & de Valk, H W 2023, ' Response to : Letter to the Editor with Regard to the Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands ', Advances in therapy, vol. 40, no. 5, pp. 2545-2548 . https://doi.org/10.1007/s12325-023-02431-2
Serné, E H, Roze, S, Buompensiere, M I, Valentine, W J, de Portu, S & de Valk, H W 2023, ' Response to : Letter to the Editor with Regard to the Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands ', Advances in therapy, vol. 40, no. 5, pp. 2545-2548 . https://doi.org/10.1007/s12325-023-02431-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4940f0bf96f287ae547184f56168ac8
https://research.vumc.nl/en/publications/d93ec4cc-68ad-4f09-a65f-fc1d98eacc3b
https://research.vumc.nl/en/publications/d93ec4cc-68ad-4f09-a65f-fc1d98eacc3b
Autor:
Lutz Heinemann, Trung Nguyen, Timothy S. Bailey, Ahmed Hassoun, Bernd Kulzer, Teresa Oliveria, Yves Reznik, Harold W. de Valk, Julia K. Mader
Publikováno v:
Journal of Diabetes Science and Technology. 17:449-457
Innovations in syringe and pen needle (PN) technology over the last 100 years have led to important advances in insulin delivery for people with diabetes, paralleling the strides made in developing recombinant DNA human insulin and insulin analogs wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4a780abf1193e58fd22a26d7db7b06
https://doi.org/10.1177/19322968211059564
https://doi.org/10.1177/19322968211059564